Todd Sangster is an expert principal in Bain & Company's San Francisco office. He is a member of Bain's Healthcare practice.
He has more than 10 years of industry and consulting experience.
Todd advises clients across a range of healthcare sectors, with a particular focus in pharmaceuticals, biotechnology and diagnostics. He holds deep expertise in issues such as corporate and business unit strategy, category leadership, clinical development, commercial excellence and managed care contracting.
Prior to joining Bain in 2007, he worked as a research assistant at the Whitehead Institute for Biomedical Research.
Todd holds a PhD in Genetics from The University of Chicago and a BA in Biochemical Science from Harvard University, where he graduated magna cum laude.
- “Finding The Right Path To Category Leadership In Oncology,” In Vivo, 3. Juni 2017, Artikel
- “Focus Matters: How Biopharma Can Reward Shareholders,” Brief, 29. November 2016
- “New Paths to Value Creation in Pharma,” Brief, 24. September 2014